Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells
about
Cancer Recurrence and Regional Anesthesia: The Theories, the Data, and the Future in Outcomes.Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL.Mitigation of indomethacin-induced gastrointestinal damages in fat-1 transgenic mice via gate-keeper action of ω-3-polyunsaturated fatty acids.Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1.Indomethacin-enhanced anticancer effect of arsenic trioxide in A549 cell line: involvement of apoptosis and phospho-ERK and p38 MAPK pathwaysIndomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa: a novel role of mitochondrial aconitase oxidation.
P2860
Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Indomethacin-induced activatio ...... bicin resistance in SCLC cells
@en
type
label
Indomethacin-induced activatio ...... bicin resistance in SCLC cells
@en
prefLabel
Indomethacin-induced activatio ...... bicin resistance in SCLC cells
@en
P2093
P2860
P356
P1476
Indomethacin-induced activatio ...... bicin resistance in SCLC cells
@en
P2093
D C J Spierings
D J A de Groot
E G E de Vries
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602516
P407
P577
2005-04-01T00:00:00Z